HE4 appears to be on its own to be as sensitive as CA125 for identifying ovarian cancer, but does not seem to make very many mistakes in a benign ovarian disease.

At every front biomarkers are playing a key role.

Predicting whether or not you have the disease and it's very early, or even once you have a disease helping you predict what treatments may respond.

The cancer was contained within the prostate and has been completely removed. We expect that his cancer is cured.

With a cancer patient, the person knows and is aware of a lot of the things going on. But in dementia patients, that is not the case.

Diagnosis of ovarian cancer is made so difficult, because the symptoms overlap with so many others for benign conditions that affect the over-50 age group. But, being aware of your body and noting when things change could save your life.